Showing 171-180 of 333 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| A pilot study assessing the safety of using a monoclonal antibody against CD40 ligand to achieve a calcineurin inhibitor-free immunosuppression regimen in patients with type 1 diabetes mellitus (T1D) and problematic hypoglycemia undergoing islet cell transplantation | The University of Chicago | Piotr Witkowski | Cures | 01-February-2024 to 31-January-2026 | $250.000,00 |
| Armored SC-beta | The Regents of the University of California, San Francisco | Qizhi Tang | Cures | 01-December-2023 to 30-November-2025 | $499.999,25 |
| Early identification strategies to assist with prevention of eating disorders (insulin restriction) in Type 1 diabetes | Penn State College of Medicine | Heather Stuckey | Improving Lives | 01-October-2023 to 30-September-2026 | $488.976,45 |
| Engineering inflammation resistant beta cells | Yale University | Kevan Herold | Cures | 01-September-2023 to 31-August-2025 | $499.999,37 |
| Charting a Path for Continuous Insulin Monitoring | University of Cincinnati | Ryan White | Improving Lives | 01-April-2024 to 31-March-2027 | $708.147,00 |
| A Nanosensor Embedded Device for Rapid Insulin Measurement | Massachusetts Institute of Technology | Michael Strano | Improving Lives | 01-April-2024 to 31-March-2027 | $600.000,00 |
| GLUT1 Inhibition in type 1 diabetes | Beckman Research Institute of the City of Hope | Alberto Pugliese | Cures | 01-November-2022 to 31-July-2026 | $494.072,25 |
| Testing the role of the PI3K-AKT-FOXO1-CXCR4 pathway in the bone marrow selection of anti-insulin B cells in T1D | Regents of the University of Colorado | Roberta Pelanda | Cures | 01-November-2023 to 31-October-2026 | $826.284,00 |
| Clinical Trial of Denosumab for Type 1 Diabetes | Beckman Research Institute of the City of Hope | Rupangi Vasavada | Cures | 01-October-2023 to 30-September-2026 | $2.232.400,00 |
| Co-transplantation of adaptive human endothelium and islets within encapsulated angiogenic hydrogels for durable engraftment | Weill Medical College of Cornell University | Shahin Rafii | Cures | 01-December-2023 to 30-November-2026 | $1.000.000,00 |